Using the ProteOn™ XPR36 to Characterize Human-Derived Monoclonal Antibodies Against Influenza Virus

1,030 views

|

March 15, 2017

"For more information, visit http://www.bio-rad.com/yt/8/proteonxpr36 Different strains of Influenza virus include a great diversity of antigenic proteins, often requiring annual vaccination for strain-specific protection. This webinar focuses on the use of the ProteOn XPR36 system to determine the cross-reactivity and binding kinetics of a panel of human-derived monoclonal antibodies against the H3 hemagglutinin protein in multiple Influenza strains. The ability to robustly measure the binding affinities of a panel of antibodies with numerous antigens using the ProteOn system is a powerful platform that is applicable to many experimental systems. It allows real-time comparison of multiple interactions on a single chip, and provides high throughput in obtaining the screening result. Presenter: Dr Lisa Scalfone, Postdoctoral Fellow Stanford University School of Medicine http://www.bio-rad.com/evportal/destination/solutions?catID=LUSLTJE8Z&WT.mc_id=yt-pfd-ww-proteonxpr36-20121030-CSAvdT-jMtM"

Drug Discovery

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.